Human breast cancer chronic intermittent hypoxia cell line, and preparation method thereof
A human breast cancer, intermittent technology, applied in tumor/cancer cells, biochemical equipment and methods, animal cells, etc., can solve the lack of in vivo experimental support, the current status of chronic intermittent hypoxia cell line culture can not meet the hypoxia related Research and other issues to achieve the effect of fast proliferation, strong invasive ability, and improved quality level
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0030] Embodiment 1 establishes MCF-7H cell line
[0031] The human breast cancer cell line MCF-7 was used as the source cell, and the in vitro culture method of chronic intermittent hypoxia was used for passage, and a stable growth cell line of chronic intermittent hypoxia was established, and the human breast cancer chronic intermittent hypoxia cell line MCF was obtained. -7H, has been preserved on May 20, 2011, preservation unit: General Microbiology Center (CGMCC), China Committee for the Collection of Microbial Cultures, address: No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing, Institute of Microbiology, Chinese Academy of Sciences , deposit number: CGMCC No.4902, classification designation: human breast cancer cells, MCF-7H.
[0032]In this example, the source cell human breast cancer cell line MCF-7 was cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum, 100 IU / ml penicillin and 100 μg / ml streptomycin; The hypoxia period of 1 hour and th...
Embodiment 2
[0035] Example 2 Human breast cancer chronic intermittent hypoxia cell line MCF-7H in vitro and in vivo culture, experiment
[0036] The results of in vitro culture of the human breast cancer chronic intermittent hypoxia cell line MCF-7H of the present invention show that the cell line has the following biological characteristics: good growth in vitro culture, passage once every 3 days; cells in multipolar epithelial morphology Features, aggregated into sheets or clusters, abundant cytoplasm, adherent growth, loss of contact growth inhibition, no obvious difference in morphology from the source cells (such as figure 1 shown); the doubling time of the cell line was about 8 hours, while the doubling time of the source cells was about 27 hours. The cell growth curve traced by the CCK-8 method suggested that the proliferation rate of MCF-7H cells was significantly faster than that of the source cells (P figure 2 shown); the results of Transwell invasion assay confirmed that MCF-...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com